Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Feb 28, 2024 $22.60 $22.76 $21.92 $22.55 1 010 176
Feb 27, 2024 $22.85 $23.09 $22.63 $22.71 722 399
Feb 26, 2024 $21.95 $22.66 $21.95 $22.63 740 737
Feb 23, 2024 $22.26 $22.38 $21.48 $22.01 893 880
Feb 22, 2024 $21.88 $22.59 $21.32 $22.25 991 986
Feb 21, 2024 $22.02 $22.48 $21.74 $22.20 772 315
Feb 20, 2024 $23.15 $23.19 $22.06 $22.17 1 528 348
Feb 16, 2024 $25.30 $25.30 $23.21 $23.27 1 556 346
Feb 15, 2024 $26.14 $26.25 $25.26 $25.41 1 566 888
Feb 14, 2024 $25.25 $27.39 $23.63 $25.75 2 833 037
Feb 13, 2024 $23.06 $23.76 $22.53 $23.02 1 435 619
Feb 12, 2024 $23.50 $24.13 $23.35 $23.83 1 184 125
Feb 09, 2024 $23.85 $24.23 $23.25 $23.69 787 198
Feb 08, 2024 $23.94 $24.13 $23.52 $23.78 653 361
Feb 07, 2024 $24.79 $24.89 $23.72 $23.91 619 583
Feb 06, 2024 $24.19 $24.91 $23.87 $24.72 788 513
Feb 05, 2024 $24.46 $24.56 $23.83 $24.27 575 268
Feb 02, 2024 $25.59 $25.61 $24.39 $24.77 568 703
Feb 01, 2024 $25.75 $26.17 $25.46 $26.00 929 011
Jan 31, 2024 $25.87 $26.60 $25.51 $25.64 746 207
Jan 30, 2024 $26.27 $26.36 $25.43 $25.90 772 975
Jan 29, 2024 $26.17 $26.78 $25.70 $26.54 594 321
Jan 26, 2024 $26.44 $26.99 $26.02 $26.36 422 712
Jan 25, 2024 $26.84 $27.68 $25.97 $26.27 462 717
Jan 24, 2024 $27.05 $27.10 $26.44 $26.51 603 989
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT